Treatment of acute HIV-1 infection: are we getting there?

作者: Cristina Cellerai , Susan J Little , Sabine Kinloch-de Loes

DOI: 10.1097/COH.0B013E3282F31D4B

关键词:

摘要: Purpose of review Treatment primary HIV-1 infection may alter the natural history and delay need for chronic antiretroviral therapy; it also be a public health measure. We discuss results therapeutic trials cohort studies, occurrence transmitted drug resistance, recent findings in terms immunopathogenesis decay viral reservoirs. Recent Events at time are understood to set scene persistence immunologic damage immune activation, with rapid onslaught primarily on memory CD4+ T cells mucosal effector sites. The initiation therapy has been associated high degree undetectable viremia compliant patients substantial reservoirs peripheral blood. reconstitution gut level, however, does not appear comparable that Summary insights into long-term consequences early burst replication – together onward transmission, possibility important steps helping design future strategies an era intense vaccine development.

参考文章(96)
Loïc Desquilbet, Cécile Goujard, Christine Rouzioux, Martine Sinet, Christiane Deveau, Mairie-Laure Chaix, Daniel Séréni, Faroudy Boufassa, Jean-François Delfraissy, Laurence Meyer, Does transient HAART during primary HIV-1 infection lower the virological set-point? AIDS. ,vol. 18, pp. 2361- 2369 ,(2004)
Diana Finzi, Joel Blankson, Janet D. Siliciano, Joseph B. Margolick, Karen Chadwick, Theodore Pierson, Kendall Smith, Julianna Lisziewicz, Franco Lori, Charles Flexner, Thomas C. Quinn, Richard E. Chaisson, Eric Rosenberg, Bruce Walker, Stephen Gange, Joel Gallant, Robert F. Siliciano, Latent infection of CD4 + T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy Nature Medicine. ,vol. 5, pp. 512- 517 ,(1999) , 10.1038/8394
Kaldor J, Porter K, Lampe Fc, Phillips An, Kinloch-de Loes S, Law M, Effect of transient antiretroviral treatment during acute HIV infection: comparison of the Quest trial results with CASCADE natural history study. Antiviral Therapy. ,vol. 12, pp. 189- 193 ,(2007)
Anton Pozniak, Clifford Leen, Valerie Delpech, Mark Gompels, Brian Gazzard, Achim Schwenk, Sarah Fidler, Philippa Easterbrook, Esther Fearnhill, Ian Chrystie, Kholoud Porter, Mark Zuckerman, Richard Gilson, Martin Fisher, Erasmus Smit, Jane Anderson, UK Chic Steering Comm, Duncan Churchill, Rob Gifford, Andrew Phillips, Paul Kellam, Ian Williams, Margaret Johnson, Chloe Orkin, Jonathan Ainsworth, Hannah Green, Anna Maria Geretti, UK Register Hiv Seroconverters Ste, Harold Jaffe, Andrew Leigh Brown, Anne Johnson, Ken McLean, Abdel Babiker, Caroline Sabin, Janet Darbyshire, David Goldberg, Deenan Pillay, David Dunn, Porton Down, Sheila Cameron, Tariq Sadiq, Teresa Hill, Gerry Robb, David Hawkins, Sheila Burns, Peter Tilston, Steve Kaye, John Walsh, Ray Brettle, Antony Hale, Patricia Cane, Evidence of a decline in transmitted HIV-1 drug resistance in the United Kingdom AIDS. ,vol. 21, pp. 1035- 1039 ,(2007)
Eric S. Rosenberg, Marcus Altfeld, Samuel H. Poon, Mary N. Phillips, Barbara M. Wilkes, Robert L. Eldridge, Gregory K. Robbins, Richard T. D'Aquila, Philip J. R. Goulder, Bruce D. Walker, Immune control of HIV-1 after early treatment of acute infection Nature. ,vol. 407, pp. 523- 526 ,(2000) , 10.1038/35035103
Victoria Manuelli, Patrick Jean-Pierre, Peter Lopez, Anita Shet, Andrea Low, Hiroshi Mohri, Daniel Boden, Paul Racz, Martin Markowitz, Saurabh Mehandru, Michael A. Poles, Klara Tenner-Racz, Mechanisms of Gastrointestinal CD4+ T-Cell Depletion during Acute and Early Human Immunodeficiency Virus Type 1 Infection Journal of Virology. ,vol. 81, pp. 599- 612 ,(2007) , 10.1128/JVI.01739-06
Jakob Nilsson, Sabine Kinloch-de-Loes, Anna Granath, Anders Sönnerborg, Li-Ean Goh, Jan Andersson, Early immune activation in gut-associated and peripheral lymphoid tissue during acute HIV infection. AIDS. ,vol. 21, pp. 565- 574 ,(2007) , 10.1097/QAD.0B013E3280117204
Amalio Telenti, Manuel Battegay, Thomas Perneger, Pietro Vernazza, Sabine Yerly, Bernard Hirschel, Hansjakob Furrer, Martin Rickenbach, Jean-Philippe Chave, Markus Flepp, Stéphanie Jost, Laurent Kaiser, Luc Perrin, Martin Gebhardt, Marie-Charlotte Bernard, Philippe Burgisser, Bruno Chanzy, Infrequent transmission of HIV-1 drug-resistant variants. Antiviral Therapy. ,vol. 9, pp. 375- 384 ,(2004)
Anita Shet, Leslie Berry, Hiroshi Mohri, Saurabh Mehandru, Chris Chung, Alexandria Kim, Patrick Jean-Pierre, Christine Hogan, Viviana Simon, Daniel Boden, Martin Markowitz, Tracking the prevalence of transmitted antiretroviral drug-resistant HIV-1: a decade of experience. Journal of Acquired Immune Deficiency Syndromes. ,vol. 41, pp. 439- 446 ,(2006) , 10.1097/01.QAI.0000219290.49152.6A
Andrea Kovacs, Mark Connors, HIV-1 and immune control: can we change the course of HIV-1? The Lancet. ,vol. 363, pp. 833- 834 ,(2004) , 10.1016/S0140-6736(04)15770-X